Alterity Therapeutics Limited earnings per share and revenue

ATHE earnings per share for the last semiannual are -0.85 USD whereas the estimation was -0.11 USD which accounts for -702.76% surprise. Company revenue for the same period amounts to 77.10 k USD despite the estimated figure of 958.26 k USD. Estimated earnings per share for the next semiannual are -0.05 USD, and revenue is expected to reach 910.15 k USD. Also watch annual changes over time to get a bigger picture of ATHE earnings per share and revenue dynamics.